Back
UroGen Pharma Vs. Stoke Therapeutics Industry Stock Comparison
Buy
51
URGN
UroGen Pharma
Last Price:
12.47
Seasonality Move:
14.66%
Sell
37
STOK
Stoke Therapeutics
Last Price:
12.59
Seasonality Move:
14.1%
Buy
51
UroGen Pharma (URGN)
is a Buy
Is UroGen Pharma a Buy, Sell or Hold?
- The current UroGen Pharma [URGN] share price is $12.47. The Score for URGN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- URGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy, Sell or Hold?
- The current Stoke Therapeutics [STOK] share price is $12.52. The Score for STOK is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- STOK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
URGN Stock Price Chart
What is UroGen Pharma's stock price today?
-
The UroGen Pharma share price today is $12.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
STOK Stock Price Chart
What is Stoke Therapeutics's stock price today?
-
The Stoke Therapeutics share price today is $12.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing slight selling pressure.
URGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 45.42 | Sell |
Chaikin Money Flow: | 215195 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.27 - 13.13) | Sell |
Bollinger Bands (100): | (12.84 - 16.3) | Sell |
STOK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 46.33 | Sell |
Chaikin Money Flow: | -80410 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.7 - 13.78) | Sell |
Bollinger Bands (100): | (12.83 - 15.29) | Sell |
URGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.42 | Buy |
20-day SMA: | 12.56 | Sell |
50-day SMA: | 13.41 | Sell |
200-day SMA: | 14.93 | Sell |
8-day EMA: | 12.49 | Sell |
20-day EMA: | 12.65 | Sell |
50-day EMA: | 13.34 | Sell |
200-day EMA: | 14.25 | Sell |
STOK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.48 | Buy |
20-day SMA: | 12.3 | Buy |
50-day SMA: | 13.63 | Sell |
200-day SMA: | 11.47 | Buy |
8-day EMA: | 12.55 | Sell |
20-day EMA: | 12.67 | Sell |
50-day EMA: | 13.25 | Sell |
200-day EMA: | 11.96 | Buy |
UroGen Pharma Earnings Growth & URGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.62 per share.
Stoke Therapeutics Earnings Growth & STOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.39 per share.
UroGen Pharma Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Stoke Therapeutics Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |